Cytochrome P450 2U1 Is a Novel Independent Prognostic Biomarker in Breast Cancer Patients
Background: The susceptibility of breast cancer is largely affected by the metabolic capacity of breast tissue. This ability depends in part on the expression profile of cytochrome P450 (CYPs). CYPs are a superfamily of enzymes with related catalysis to endogenous and exogenous bioactive substances,...
Main Authors: | Bin Luo, Chuang Chen, Xiaoyan Wu, Dandan Yan, Fangfang Chen, Xinxin Yu, Jingping Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01379/full |
Similar Items
-
Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response
by: Viktor Hlaváč, et al.
Published: (2021-03-01) -
Engineering cytochrome P450s for bioremediation /
by: 242771 Kellner, David G., et al. -
The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
by: Freeborn Rwere, et al.
Published: (2021-09-01) -
The use of active site mutants of cytochrome P450(cam) in chemical synthesis
by: Bell, S, et al.
Published: (1999) -
Gut transcriptome analysis of P450 genes and cytochrome P450 reductase in three moth species feeding on gymnosperms or angiosperms
by: Xiaoman Zhang, et al.
Published: (2022-11-01)